It’s not yet two weeks since the Supreme Court overturned Roe v. Wade, and already the ruling is impeding people’s access to drugs — including drugs not being used for abortions.
State trigger laws now going into effect are of course making it harder and sometimes illegal for women to get medication abortion, the two-pill regimen approved by the Food and Drug Administration to end early pregnancies. But emergency contraceptives and the autoimmune-disease treatment methotrexate are also being caught up by overly broad interpretations of abortion bans.
So far, pharma companies have been silent on these restrictions. Perhaps many of them simply assume that the loss of mifepristone is no risk to their bottom lines. But any state restrictions on FDA-approved drugs could amount to a worrisome precedent.
